Doxepin 150mg Capsules

Manufacturer PAR Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS e pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Hypnotic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA), Histamine H1 Receptor Antagonist
🤰
Pregnancy Category
C
✅
FDA Approved
Mar 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication used to treat depression and anxiety. It works by affecting certain natural chemicals in your brain. At higher doses, it's an antidepressant, and at very low doses, it can be used to help with sleep. This 150mg capsule is typically for depression or anxiety.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your medication and follow the instructions closely. If you're taking this medication once a day, take it at bedtime. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel well.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. Instead, check with your pharmacist for guidance on the best disposal method, or look into local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications, as doxepin can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • Rise slowly from a sitting or lying position to prevent dizziness or fainting.
  • Maintain good oral hygiene due to potential for dry mouth.
  • Avoid excessive sun exposure as doxepin may increase sensitivity to sunlight.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For depression/anxiety: Initial 25-75 mg/day, typically given in a single dose at bedtime or in divided doses. Usual therapeutic range 75-150 mg/day. Max 300 mg/day. For insomnia (low-dose formulation, e.g., Silenor): 3-6 mg once daily at bedtime.
Dose Range: 25 - 300 mg

Condition-Specific Dosing:

depression_anxiety: Initial 25-75 mg/day, usual 75-150 mg/day, max 300 mg/day. Doses above 150 mg/day should be given in divided doses.
insomnia: 3-6 mg once daily at bedtime (for low-dose doxepin formulations, not the 150mg capsule).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (safety and efficacy not established for depression/anxiety; black box warning for suicidality)
Adolescent: Not established (safety and efficacy not established for depression/anxiety; black box warning for suicidality)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required, but monitor for adverse effects.
Moderate: Use with caution; consider lower initial doses and slower titration.
Severe: Use with caution; consider lower initial doses and slower titration. Monitor closely for adverse effects.
Dialysis: Not well studied; doxepin is highly protein-bound and not significantly removed by dialysis. Use with extreme caution and monitor for toxicity.

Hepatic Impairment:

Mild: Use with caution; consider lower initial doses and slower titration.
Moderate: Significant dose reduction may be necessary (e.g., 50% or more of usual dose). Monitor plasma levels if possible.
Severe: Contraindicated or use with extreme caution and significant dose reduction. Monitor closely for toxicity.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at the presynaptic neuronal membrane, thereby increasing the concentration of these neurotransmitters in the synaptic cleft. It also possesses potent antihistaminic (H1), moderate anticholinergic (muscarinic), and moderate alpha-1 adrenergic receptor blocking properties. Its sedative effects are largely attributed to its potent H1 antagonism, while its antidepressant effects are linked to NE and 5-HT reuptake inhibition.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (due to extensive first-pass metabolism), approximately 13-45%
Tmax: 2-4 hours (parent drug), 6-12 hours (active metabolite, nordoxepin)
FoodEffect: Food may delay Tmax but does not significantly affect AUC.

Distribution:

Vd: Approximately 9-33 L/kg (large volume of distribution)
ProteinBinding: >90% (primarily to albumin)
CnssPenetration: Yes

Elimination:

HalfLife: Doxepin: 10-25 hours; Nordoxepin: 28-52 hours
Clearance: Not readily available, but extensive hepatic metabolism and renal excretion.
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: <3% (parent drug)
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative effects: within hours; Antidepressant effects: 2-4 weeks (full effect may take longer)
PeakEffect: Sedative effects: 2-4 hours; Antidepressant effects: 4-6 weeks
DurationOfAction: Due to long half-life, effects persist for 24 hours, allowing once-daily dosing for depression/anxiety. Sedative effects for insomnia last 7-8 hours.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex interest
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Worsening of asthma symptoms has been reported in people taking this drug. If your asthma symptoms worsen while taking this medication, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug may cause side effects. Many people experience no side effects or only mild ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or thoughts about harming yourself (especially at the beginning of treatment or after a dose change).
  • Unusual changes in behavior, such as agitation, restlessness, panic attacks, irritability, aggression, or mania.
  • Severe dry mouth, blurred vision, or difficulty urinating.
  • Fast, pounding, or irregular heartbeat.
  • Severe constipation.
  • Confusion or disorientation, especially in older adults.
  • Muscle stiffness, high fever, sweating, confusion, fast or irregular heartbeat, or severe muscle stiffness (signs of Neuroleptic Malignant Syndrome, though rare).
  • Symptoms of Serotonin Syndrome (agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, diarrhea).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, such as:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline (as this may lead to very high blood pressure)
Use of other medications that can cause drowsiness, as there are many drugs with this potential effect. If you are unsure, consult your doctor or pharmacist.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and other activities that require you to be alert. You may not experience the full effects of the medication for several weeks.

Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. If you need to discontinue the medication, your doctor will instruct you on how to gradually stop taking it to minimize potential risks.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, before using marijuana, cannabis products, or prescription or over-the-counter medications that may cause drowsiness, consult with your doctor to discuss potential interactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when spending time outdoors, and inform your doctor if you experience excessive sunburning while taking this medication.

If you have diabetes, it is crucial to monitor your blood sugar levels closely. Be aware of the signs of high or low blood sugar, which may include fruity breath odor, dizziness, rapid breathing, rapid heartbeat, confusion, drowsiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Some medications, including this one, may affect fertility and the ability to conceive. If you have concerns or questions, discuss them with your doctor.

If you are pregnant or planning to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy. Taking this medication in the third trimester may pose health risks to the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion or agitation
  • Severe dry mouth
  • Blurred vision
  • Dilated pupils
  • Fast, irregular, or pounding heartbeat (arrhythmias)
  • Low blood pressure (hypotension)
  • Respiratory depression (slow, shallow breathing)
  • Seizures
  • Urinary retention
  • Hypothermia

What to Do:

If you suspect an overdose, seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of hyperpyretic crisis, severe convulsions, and death. Allow at least 14 days between discontinuing MAOI and starting doxepin, and vice versa.
  • Cisapride - increased risk of QT prolongation and arrhythmias.
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics, antihistamines) - additive CNS depression, increased sedation, respiratory depression.
  • Anticholinergic Agents (e.g., atropine, benztropine, diphenhydramine, antipsychotics) - additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, delirium).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine, pseudoephedrine) - potentiation of cardiovascular effects (hypertension, arrhythmias).
  • QT Prolonging Drugs (e.g., antiarrhythmics like quinidine, procainamide; some antipsychotics like thioridazine; some antibiotics like moxifloxacin) - increased risk of QT prolongation and Torsades de Pointes.
  • CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine, cimetidine) - can significantly increase doxepin and nordoxepin plasma concentrations, leading to increased toxicity.
  • Thyroid Hormones - increased risk of cardiac arrhythmias and toxicity.
🟡

Moderate Interactions

  • CYP1A2 Inhibitors (e.g., fluvoxamine, ciprofloxacin) - may increase doxepin levels.
  • CYP2C19 Inhibitors (e.g., omeprazole, fluoxetine) - may increase doxepin levels.
  • CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir) - may increase doxepin levels.
  • Antihypertensives (especially adrenergic neuron blockers like guanethidine, clonidine) - doxepin may antagonize their hypotensive effects.
  • Warfarin - potential for altered anticoagulant effect (monitor INR).
đŸŸĸ

Minor Interactions

  • Tobacco Smoking - may induce CYP1A2, potentially decreasing doxepin levels.
  • Grapefruit Juice - theoretical inhibition of CYP3A4, but clinical significance is minor.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Psychiatric Evaluation

Rationale: To assess baseline symptoms, suicidality risk, and suitability for doxepin therapy.

Timing: Prior to initiation

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities (e.g., prolonged QT interval) due to doxepin's potential for cardiac effects.

Timing: Prior to initiation, especially in elderly or those with cardiac risk factors

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as doxepin is extensively metabolized by the liver.

Timing: Prior to initiation

Renal Function Tests (e.g., SCr, eGFR)

Rationale: To assess baseline renal function, as metabolites are renally excreted.

Timing: Prior to initiation

Blood Pressure and Heart Rate

Rationale: To establish baseline and monitor for orthostatic hypotension and tachycardia.

Timing: Prior to initiation

📊

Routine Monitoring

Clinical Response and Adverse Effects

Frequency: Weekly during initial titration, then monthly or as clinically indicated

Target: Improvement in target symptoms (e.g., mood, anxiety, sleep) with tolerable side effects.

Action Threshold: Lack of response, worsening symptoms, or intolerable side effects warrant dose adjustment or discontinuation.

Suicidality Assessment

Frequency: Weekly during initial titration (first 4 weeks), then every 2 weeks for the next 4 weeks, then at 12 weeks, and periodically thereafter.

Target: Absence of suicidal ideation or behavior.

Action Threshold: Emergence or worsening of suicidal thoughts or behaviors requires immediate clinical intervention.

Blood Pressure (sitting and standing) and Heart Rate

Frequency: Periodically, especially during dose titration and in elderly patients.

Target: Within normal limits, without significant orthostatic drop.

Action Threshold: Significant orthostatic hypotension (e.g., >20 mmHg systolic drop) or persistent tachycardia may require dose reduction or change in therapy.

Anticholinergic Side Effects (e.g., dry mouth, blurred vision, constipation, urinary retention)

Frequency: Routinely at each visit

Target: Minimal or manageable symptoms.

Action Threshold: Severe or unmanageable symptoms may require dose reduction or adjunctive treatment.

Therapeutic Drug Monitoring (TDM) - Doxepin and Nordoxepin plasma levels

Frequency: Not routinely recommended, but may be useful in cases of suspected non-adherence, poor response, or toxicity.

Target: Combined plasma levels of doxepin and nordoxepin typically 100-250 ng/mL for antidepressant effect.

Action Threshold: Levels outside therapeutic range may indicate need for dose adjustment or investigation of adherence/metabolism.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence or worsening of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, anxiety, panic attacks, insomnia, impulsivity, aggression, mania/hypomania)
  • Dry mouth
  • Blurred vision
  • Constipation
  • Urinary retention
  • Dizziness or lightheadedness (especially upon standing)
  • Sedation or drowsiness
  • Confusion or disorientation (especially in elderly)
  • Tremor
  • Palpitations or irregular heartbeat
  • Seizures

Special Patient Groups

🤰

Pregnancy

Doxepin is Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Neonates exposed to TCAs in the third trimester have developed withdrawal symptoms.

Trimester-Specific Risks:

First Trimester: Limited human data; animal studies show some adverse effects. Risk of congenital malformations is not clearly established but generally considered low.
Second Trimester: No specific data indicating increased risk beyond general TCA risks.
Third Trimester: Risk of neonatal withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremor, seizures) if exposed late in pregnancy. Potential for persistent pulmonary hypertension of the newborn (PPHN) has been suggested with SSRIs, but less clear for TCAs.
🤱

Lactation

Doxepin and its active metabolite, nordoxepin, are excreted into breast milk. The American Academy of Pediatrics considers doxepin to be a drug for which the effect on the nursing infant is unknown but may be of concern. Use with caution; monitor infant for sedation, poor feeding, and weight gain.

Infant Risk: L3 (Moderate risk). Potential for infant sedation, lethargy, poor feeding, and weight gain. Long half-life of the active metabolite may lead to accumulation. Consider alternative agents or monitor infant closely.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established for pediatric patients for depression or anxiety. Doxepin carries a Black Box Warning regarding increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24) treated with antidepressants. Use in this population is generally not recommended for these indications.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and hypotensive effects of doxepin. They are at increased risk for falls, cognitive impairment (delirium), and urinary retention. Start with lower doses (e.g., 10-25 mg/day) and titrate slowly. Avoid if possible in patients with dementia or significant cognitive impairment due to anticholinergic burden. Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Doxepin is highly sedating due to its potent H1 antagonism; therefore, it is often dosed at bedtime, especially for depression/anxiety.
  • The 150mg capsule is a high dose, typically reserved for moderate to severe depression or anxiety. Lower doses (e.g., 3-6 mg) are available as a separate formulation (Silenor) specifically for insomnia.
  • Significant anticholinergic side effects (dry mouth, constipation, blurred vision, urinary retention) are common, especially at higher doses, and can be particularly problematic in the elderly.
  • Due to its cardiac effects (e.g., QT prolongation, orthostatic hypotension), caution is advised in patients with pre-existing cardiac disease. A baseline ECG is recommended, especially in older adults or those with cardiac risk factors.
  • Doxepin has a narrow therapeutic index, and overdose can be life-threatening, leading to cardiac arrhythmias, severe CNS depression, and seizures.
  • Patients should be warned about the Black Box Warning for suicidality, especially young adults, and monitored closely for worsening mood or behavioral changes.
🔄

Alternative Therapies

  • Other Tricyclic Antidepressants (TCAs): Amitriptyline, Imipramine, Nortriptyline, Desipramine (differ in side effect profiles and selectivity for NE/5-HT).
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram (first-line for depression/anxiety, generally better tolerated).
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine, Desvenlafaxine.
  • Atypical Antidepressants: Bupropion, Mirtazapine, Trazodone.
  • For anxiety: Benzodiazepines (short-term), Buspirone, SSRIs/SNRIs.
  • For insomnia: Zolpidem, Eszopiclone, Zaleplon, Trazodone, Mirtazapine, Suvorexant, Lemborexant.
💰

Cost & Coverage

Average Cost: $15 - $100+ per 30 capsules (150mg)
Generic Available: Yes
Insurance Coverage: Generally covered by most commercial and government insurance plans (e.g., Medicare, Medicaid) as a Tier 1 or Tier 2 generic medication.
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for guidance. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount consumed, and the time it occurred.